140 related articles for article (PubMed ID: 28132916)
41. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
[TBL] [Abstract][Full Text] [Related]
43. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
[TBL] [Abstract][Full Text] [Related]
44. Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor.
Grieco P; Brancaccio D; Novellino E; Hruby VJ; Carotenuto A
Eur J Med Chem; 2011 Sep; 46(9):3721-33. PubMed ID: 21652123
[TBL] [Abstract][Full Text] [Related]
45. Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational states.
Nickolls SA; Fleck B; Hoare SR; Maki RA
J Pharmacol Exp Ther; 2005 Jun; 313(3):1281-8. PubMed ID: 15743921
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
47. Ligand binding to the serotonin 5HT3 receptor studied with a novel fluorescent ligand.
Tairi AP; Hovius R; Pick H; Blasey H; Bernard A; Surprenant A; Lundström K; Vogel H
Biochemistry; 1998 Nov; 37(45):15850-64. PubMed ID: 9843391
[TBL] [Abstract][Full Text] [Related]
48. Analogs of lactam derivatives of alpha-melanotropin with basic and acidic residues.
Bednarek MA; MacNeil T; Kalyani RN; Tang R; Van der Ploeg LH; Weinberg DH
Biochem Biophys Res Commun; 2000 May; 272(1):23-8. PubMed ID: 10872798
[TBL] [Abstract][Full Text] [Related]
49. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
50. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
Alvaro JD; Tatro JB; Quillan JM; Fogliano M; Eisenhard M; Lerner MR; Nestler EJ; Duman RS
Mol Pharmacol; 1996 Sep; 50(3):583-91. PubMed ID: 8794897
[TBL] [Abstract][Full Text] [Related]
51. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
[TBL] [Abstract][Full Text] [Related]
52. Enhanced targeting with heterobivalent ligands.
Xu L; Vagner J; Josan J; Lynch RM; Morse DL; Baggett B; Han H; Mash EA; Hruby VJ; Gillies RJ
Mol Cancer Ther; 2009 Aug; 8(8):2356-65. PubMed ID: 19671749
[TBL] [Abstract][Full Text] [Related]
53. An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.
Lensing CJ; Freeman KT; Schnell SM; Adank DN; Speth RC; Haskell-Luevano C
J Med Chem; 2016 Apr; 59(7):3112-28. PubMed ID: 26959173
[TBL] [Abstract][Full Text] [Related]
54. Fluorescence-Based Binding Assay for Screening Ligands of Angiotensin Receptors.
Bragina ME; Stergiopulos N; Fraga-Silva RA
Methods Mol Biol; 2017; 1614():165-174. PubMed ID: 28500603
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment.
Brabez N; Lynch RM; Xu L; Gillies RJ; Chassaing G; Lavielle S; Hruby VJ
J Med Chem; 2011 Oct; 54(20):7375-84. PubMed ID: 21928837
[TBL] [Abstract][Full Text] [Related]
56. Rigid linkers for bioactive peptides.
Vagner J; Handl HL; Monguchi Y; Jana U; Begay LJ; Mash EA; Hruby VJ; Gillies RJ
Bioconjug Chem; 2006; 17(6):1545-50. PubMed ID: 17105235
[TBL] [Abstract][Full Text] [Related]
57. BRET- and fluorescence anisotropy-based assays for real-time monitoring of ligand binding to M
Grätz L; Laasfeld T; Allikalt A; Gruber CG; Pegoli A; Tahk MJ; Tsernant ML; Keller M; Rinken A
Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118930. PubMed ID: 33347921
[TBL] [Abstract][Full Text] [Related]
58. Fluorescence based HTS-compatible ligand binding assays for dopamine D
Tahk MJ; Laasfeld T; Meriste E; Brea J; Loza MI; Majellaro M; Contino M; Sotelo E; Rinken A
Front Mol Biosci; 2023; 10():1119157. PubMed ID: 37006609
[TBL] [Abstract][Full Text] [Related]
59. Novel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design.
Gimenez LE; Martin C; Yu J; Hollanders C; Hernandez CC; Wu Y; Yao D; Han GW; Dahir NS; Wu L; Van der Poorten O; Lamouroux A; Mannes M; Zhao S; Tourwé D; Stevens RC; Cone RD; Ballet S
J Med Chem; 2024 Feb; 67(4):2690-2711. PubMed ID: 38345933
[TBL] [Abstract][Full Text] [Related]
60. Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy.
Antoine T; Ott D; Ebell K; Hansen K; Henry L; Becker F; Hannus S
Anal Biochem; 2016 Jun; 502():24-35. PubMed ID: 26954998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
